Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy J Buckle

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 31, 2005
Functional magnetic resonance imaging and multiple sclerosis: the evidence for neuronal plasticityGuy J Buckle
Neurologic Clinics|December 6, 2008
Neuroimaging in multiple sclerosisEman N Ali, Guy J Buckle
Neurology|February 26, 2003
Activated CD8+ T cells in secondary progressive MS secrete lymphotoxinGuy J Buckle, Per Höllsberg, David A Hafler
Neurologic Clinics|January 22, 2005
Immunosuppressive therapy for multiple sclerosisSusan A Gauthier, Guy J Buckle, Howard L Weiner
Neurology. Clinical Practice|March 13, 2019
Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologistEdward J Fox, Guy J Buckle, Barry Singer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2014
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapyRobert L Carruthers, Dalia L Rotstein, Brian C Healy, et al.
Science Translational Medicine|September 29, 2012
An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activityLinda Ottoboni, Brendan T Keenan, Pablo Tamayo, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 7, 2017
Characterizing Clinical and MRI Dissociation in Patients with Multiple SclerosisBrian C Healy, Guy J Buckle, Eman N Ali, et al.
Archives of Neurology|February 11, 2009
Rate of brain atrophy in benign vs early multiple sclerosisSusan A Gauthier, Annika M Berger, Zsuzsanna Liptak, et al.
Annals of Neurology|April 2, 2014
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosisSpyridon Chalkias, Xin Dang, Evelyn Bord, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 31, 2005
Functional magnetic resonance imaging and multiple sclerosis: the evidence for neuronal plasticityGuy J Buckle
Neurologic Clinics|December 6, 2008
Neuroimaging in multiple sclerosisEman N Ali, Guy J Buckle
Neurology|February 26, 2003
Activated CD8+ T cells in secondary progressive MS secrete lymphotoxinGuy J Buckle, Per Höllsberg, David A Hafler
Neurologic Clinics|January 22, 2005
Immunosuppressive therapy for multiple sclerosisSusan A Gauthier, Guy J Buckle, Howard L Weiner
Neurology. Clinical Practice|March 13, 2019
Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologistEdward J Fox, Guy J Buckle, Barry Singer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2014
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapyRobert L Carruthers, Dalia L Rotstein, Brian C Healy, et al.
Science Translational Medicine|September 29, 2012
An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activityLinda Ottoboni, Brendan T Keenan, Pablo Tamayo, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 7, 2017
Characterizing Clinical and MRI Dissociation in Patients with Multiple SclerosisBrian C Healy, Guy J Buckle, Eman N Ali, et al.
Archives of Neurology|February 11, 2009
Rate of brain atrophy in benign vs early multiple sclerosisSusan A Gauthier, Annika M Berger, Zsuzsanna Liptak, et al.
Annals of Neurology|April 2, 2014
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosisSpyridon Chalkias, Xin Dang, Evelyn Bord, et al.
Pageof 2